52 related articles for article (PubMed ID: 16475726)
1. Overexpression of UHRF1 gene correlates with the major clinicopathological parameters in urinary bladder cancer.
Saidi S; Popov Z; Janevska V; Panov S
Int Braz J Urol; 2017; 43(2):224-229. PubMed ID: 28128913
[TBL] [Abstract][Full Text] [Related]
2. Distinct Lipidomic Landscapes Associated with Clinical Stages of Urothelial Cancer of the Bladder.
Piyarathna DWB; Rajendiran TM; Putluri V; Vantaku V; Soni T; von Rundstedt FC; Donepudi SR; Jin F; Maity S; Ambati CR; Dong J; Gödde D; Roth S; Störkel S; Degener S; Michailidis G; Lerner SP; Pennathur S; Lotan Y; Coarfa C; Sreekumar A; Putluri N
Eur Urol Focus; 2018 Dec; 4(6):907-915. PubMed ID: 28753886
[TBL] [Abstract][Full Text] [Related]
3. TUMOR MARKERS EXPRESSION LEVELS IN GASTRIC CANCER PATIENT'S PERIPHERAL BLOOD BY RT-PCR ASSESSMENT.
Kawakami GDS; Pereira MA; Kubrusly MS; Carrasco AGM; Ramos MFKP; Ribeiro Júnior U
Arq Bras Cir Dig; 2024; 36():e1789. PubMed ID: 38324850
[TBL] [Abstract][Full Text] [Related]
4. [Disseminated tumour cells in bladder cancer].
Gužvić M; Engelmann S; Burger M; Mayr R
Urologie; 2022 Jul; 61(7):728-733. PubMed ID: 35925248
[TBL] [Abstract][Full Text] [Related]
5. Tumor heterogeneity in muscle-invasive bladder cancer.
Kang HW; Kim WJ; Choi W; Yun SJ
Transl Androl Urol; 2020 Dec; 9(6):2866-2880. PubMed ID: 33457261
[TBL] [Abstract][Full Text] [Related]
6. The current status and clinical value of circulating tumor cells and circulating cell-free tumor DNA in bladder cancer.
Riethdorf S; Soave A; Rink M
Transl Androl Urol; 2017 Dec; 6(6):1090-1110. PubMed ID: 29354496
[TBL] [Abstract][Full Text] [Related]
7. The prognostic and diagnostic value of circulating tumor cells in bladder cancer and upper tract urothelial carcinoma: a meta-analysis of 30 published studies.
Zhang Z; Fan W; Deng Q; Tang S; Wang P; Xu P; Wang J; Yu M
Oncotarget; 2017 Aug; 8(35):59527-59538. PubMed ID: 28938656
[TBL] [Abstract][Full Text] [Related]
8. In stage pT1 non-muscle-invasive bladder cancer (NMIBC), high KRT20 and low KRT5 mRNA expression identify the luminal subtype and predict recurrence and survival.
Breyer J; Wirtz RM; Otto W; Erben P; Kriegmair MC; Stoehr R; Eckstein M; Eidt S; Denzinger S; Burger M; Hartmann A;
Virchows Arch; 2017 Mar; 470(3):267-274. PubMed ID: 28074276
[TBL] [Abstract][Full Text] [Related]
9. Transcripts of circulating tumor cells detected by a breast cancer-specific platform correlate with clinical stage in bladder cancer patients.
Todenhöfer T; Hennenlotter J; Dorner N; Kühs U; Aufderklamm S; Rausch S; Bier S; Mischinger J; Schellbach D; Hauch S; Feniuk N; Bedke J; Gakis G; Stenzl A; Schwentner C
J Cancer Res Clin Oncol; 2016 May; 142(5):1013-20. PubMed ID: 26910601
[TBL] [Abstract][Full Text] [Related]
10. Do circulating tumor cells have a role in deciding on adjuvant chemotherapy after radical cystectomy?
Soave A; Riethdorf S; Pantel K; Fisch M; Rink M
Curr Urol Rep; 2015 Jul; 16(7):46. PubMed ID: 26025496
[TBL] [Abstract][Full Text] [Related]
11. [Molecular lymph node staging in prostate and bladder cancer].
Heck MM; Retz M; Nawroth R
Urologe A; 2014 Apr; 53(4):484-90. PubMed ID: 24671247
[TBL] [Abstract][Full Text] [Related]
12. Leukocyte-adjusted epigenome-wide association studies of blood from solid tumor patients.
Langevin SM; Houseman EA; Accomando WP; Koestler DC; Christensen BC; Nelson HH; Karagas MR; Marsit CJ; Wiencke JK; Kelsey KT
Epigenetics; 2014 Jun; 9(6):884-95. PubMed ID: 24671036
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of circulating tumor cell detection in bladder and urothelial cancer: systematic review and meta-analysis.
Msaouel P; Koutsilieris M
BMC Cancer; 2011 Aug; 11():336. PubMed ID: 21816094
[TBL] [Abstract][Full Text] [Related]
14. Molecular staging of bladder cancer with RT-PCR assay for CK20 in peripheral blood, bone marrow and lymph nodes: comparison with standard histological staging.
Ribal MJ; Mengual L; Marín M; Algaba F; Ars E; Fernández PL; Oliva R; Villavicencio H; Alcaraz A
Anticancer Res; 2006; 26(1A):411-9. PubMed ID: 16475726
[TBL] [Abstract][Full Text] [Related]
15. Value of reverse transcription polymerase chain assay in peripheral blood of patients with urothelial cancer.
Okegawa T; Kinjo M; Nutahara K; Higashihara E
J Urol; 2004 Apr; 171(4):1461-6. PubMed ID: 15017198
[TBL] [Abstract][Full Text] [Related]
16. [Clinical significance of detecting lymph node micrometastasis of colorectal cancer by reverse transcriptase-polymerase chain reaction (RT-PCR)].
Yuan HY; Cheng FL; Wei ZZ; Yang GL; Chen JK
Ai Zheng; 2004 Sep; 23(9):1069-73. PubMed ID: 15363204
[TBL] [Abstract][Full Text] [Related]
17. Quantitative detection of cytokeratin 20 mRNA in urine samples as diagnostic tools for bladder cancer by real-time PCR.
Guo B; Luo C; Xun C; Xie J; Wu X; Pu J
Exp Oncol; 2009 Mar; 31(1):43-7. PubMed ID: 19300416
[TBL] [Abstract][Full Text] [Related]
18. [The current status of molecular detection of micrometastatic prostate cancer cells].
Deguchi T; Yang M; Yasuda M; Yokoi S; Nishino Y; Ehara H; Yamamoto N; Takahashi Y; Ishihara S
Hinyokika Kiyo; 1999 Aug; 45(8):565-9. PubMed ID: 10500964
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow and sentinel lymph node biopsy in patients with breast cancer: from staging to ultrastaging?
Fortunato L; Baldi A; Farina M; Campioni M; Amini M; Piro FR; Costarelli L; Pompili P; Vitelli CE
J Exp Clin Cancer Res; 2006 Dec; 25(4):487-93. PubMed ID: 17310838
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
